Catalytic asymmetric synthesis of cannabinoids and menthol from neral

The selective conversion of natural or synthetic neral to (1R,6S)-trans-isopiperitenol would enable and expedite sustainable routes to menthol(1,2) and cannabinoids(3-5). However, this reaction has been considered impossible because its product is more reactive to the required acid catalysts than its starting material, resulting in several side products(6-9). We now show that an unsymmetric, strong and confined chiral acid, a highly fluorinated imino-imidodiphosphate, catalyses this process with excellent efficiency and selectivity. Expanding the method to other alpha,beta-unsaturated aldehydes could enable access to new cannabinoids and menthol derivatives not readily accessible previously. Mechanistic studies suggest that the confined catalyst accomplishes this reaction by binding the product in an unreactive conformation, thereby preventing its decomposition. We also show how (1R,6S)-trans-isopiperitenol can be readily converted to pharmaceutically useful cannabinoids and menthol, each in the shortest and most atom-economic routes so far.

Automated summary

The discovery of a highly efficient and selective catalyst enables the conversion of natural or synthetic neral to (1R,6S)-trans-isopiperitenol, providing sustainable routes to menthol and cannabinoids.